Raffa Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Raffa Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76K	Buy	6 +1	+20%	+$284	﹤0.01%	870
2026 Q1	$1.39K	Hold	5	–	–	﹤0.01%	855
2025 Q4	$1.51K	Hold	5	–	–	﹤0.01%	814
2025 Q3	$1.4K	Sell	5 -30	-86%	-$8.16K	﹤0.01%	811
2025 Q2	$8.45K	Buy	35 +30	+600%	+$7.09K	﹤0.01%	410
2025 Q1	$1.22K	Hold	5	–	–	﹤0.01%	773
2024 Q4	$1.64K	Hold	5	–	–	﹤0.01%	723
2024 Q3	$1.67K	Hold	5	–	–	﹤0.01%	685
2024 Q2	$1.37K	Hold	5	–	–	﹤0.01%	812
2024 Q1	$1.73K	Hold	5	–	–	﹤0.01%	743
2023 Q4	$1.61K	Hold	5	–	–	﹤0.01%	685
2023 Q3	$1.79K	Hold	5	–	–	﹤0.01%	618
2023 Q2	$1.9K	Hold	5	–	–	﹤0.01%	621
2023 Q1	$2.4K	Hold	5	–	–	﹤0.01%	557
2022 Q4	$2.1K	Hold	5	–	–	﹤0.01%	574
2022 Q3	$2.09K	Hold	5	–	–	﹤0.01%	586
2022 Q2	$2.48K	Hold	5	–	–	﹤0.01%	553
2022 Q1	$2.82K	Hold	5	–	–	﹤0.01%	546
2021 Q4	$3.78K	Hold	5	–	–	﹤0.01%	497
2021 Q3	$3.73K	Hold	5	–	–	﹤0.01%	451
2021 Q2	$3.22K	Hold	5	–	–	﹤0.01%	490
2021 Q1	$2.86K	Buy	5 +1	+25%	+$592	﹤0.01%	539
2020 Q4	$2.33K	Hold	4	–	–	﹤0.01%	517
2020 Q3	$2.06K	Hold	4	–	–	﹤0.01%	489
2020 Q2	$1.81K	Hold	4	–	–	﹤0.01%	498
2020 Q1	$1.4K	Hold	4	–	–	﹤0.01%	498
2019 Q4	$1.48K	Hold	4	–	–	﹤0.01%	477
2019 Q3	$1.33K	Buy	+4	New	+$1.3K	﹤0.01%	494
2019 Q2	–	Sell	-4	Closed	-$1.22K	–	815
2019 Q1	$1.22K	Hold	4	–	–	﹤0.01%	487
2018 Q4	$929	Hold	4	–	–	﹤0.01%	566
2018 Q3	$1.25K	Hold	4	–	–	﹤0.01%	508
2018 Q2	$1.15K	Hold	4	–	–	﹤0.01%	517
2018 Q1	$1K	Buy	+4	New	+$1.02K	﹤0.01%	552

Other funds holding BIO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Raffa Wealth Management's BIO Position: Q2 2026 in Review

Raffa Wealth Management increased its Bio-Rad Laboratories Class A (BIO) stake by 20% in Q2 2026, buying an estimated $284 and bringing the position to 6 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #870.

Raffa Wealth Management first reported a position in BIO in Q1 2018 and has held it in 33 quarters since. The position peaked at $8.45K in Q2 2025. 370 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Raffa Wealth Management held 6 shares of Bio-Rad Laboratories Class A worth $1.76K as of Q2 2026.
Raffa Wealth Management bought 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
Bio-Rad Laboratories Class A made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #870 holding.
Raffa Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 33 quarters since.
Raffa Wealth Management's Bio-Rad Laboratories Class A position peaked at $8.45K in Q2 2025.
370 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.